These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8781548)

  • 1. The S29 ribosomal protein increases tumor suppressor activity of K rev-1 gene on v-K ras-transformed NIH3T3 cells.
    Kondoh N; Noda M; Fisher RJ; Schweinfest CW; Papas TS; Kondoh A; Samuel KP; Oikawa T
    Biochim Biophys Acta; 1996 Aug; 1313(1):41-6. PubMed ID: 8781548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic analysis of the Kirsten-ras-revertant 1 gene: potentiation of its tumor suppressor activity by specific point mutations.
    Kitayama H; Matsuzaki T; Ikawa Y; Noda M
    Proc Natl Acad Sci U S A; 1990 Jun; 87(11):4284-8. PubMed ID: 2112251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transformation suppressor genes.
    Noda M; Kitayama H; Kanazawa S; Murata S; Matsuzaki T; Ikawa Y
    Princess Takamatsu Symp; 1989; 20():233-9. PubMed ID: 2518686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of the K-rev-1 transformation-suppressor gene.
    Kitayama H; Matsuzaki T; Sugimoto Y; Ikawa Y; Noda M
    Environ Health Perspect; 1991 Jun; 93():73-7. PubMed ID: 1773804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A domain responsible for the transformation suppressor activity in Krev-1 protein.
    Kitayama H; Matsuzaki T; Ikawa Y; Noda M
    Jpn J Cancer Res; 1990 May; 81(5):445-8. PubMed ID: 2116391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial growth suppression of human prostate cancer cells by the Krev-1 suppressor gene.
    Burney TL; Rockove S; Eiseman JL; Jacobs SC; Kyprianou N
    Prostate; 1994 Oct; 25(4):177-88. PubMed ID: 8084835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversion of middle T antigen-transformed Rat-2 cells by Krev-1: implications for the role of p21c-ras in polyomavirus-mediated transformation.
    Jelinek MA; Hassell JA
    Oncogene; 1992 Sep; 7(9):1687-98. PubMed ID: 1380149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of azatyrosine-induced revertants from ras-transformed human mammary epithelial cells.
    Kyprianou N; Taylor-Papadimitriou J
    Oncogene; 1992 Jan; 7(1):57-63. PubMed ID: 1741165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential gene expression in apoptosis: identification of ribosomal protein S29 as an apoptotic inducer.
    Khanna N; Reddy VG; Tuteja N; Singh N
    Biochem Biophys Res Commun; 2000 Oct; 277(2):476-86. PubMed ID: 11032747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of genes specifically expressed in flat revertant cells derived from activated ras-transformed NIH 3T3 cells by treatment with azatyrosine.
    Krzyzosiak WJ; Shindo-Okada N; Teshima H; Nakajima K; Nishimura S
    Proc Natl Acad Sci U S A; 1992 Jun; 89(11):4879-83. PubMed ID: 1594588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc finger-like motifs in rat ribosomal proteins S27 and S29.
    Chan YL; Suzuki K; Olvera J; Wool IG
    Nucleic Acids Res; 1993 Feb; 21(3):649-55. PubMed ID: 8441676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a human MSX-2 cDNA and its fragment isolated as a transformation suppressor gene against v-Ki-ras oncogene.
    Takahashi C; Akiyama N; Matsuzaki T; Takai S; Kitayama H; Noda M
    Oncogene; 1996 May; 12(10):2137-46. PubMed ID: 8668339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Rap 1 suppresses genomic instability of H-ras transformed mouse fibroblasts.
    Wani MA; Denko NC; Stambrook PJ
    Somat Cell Mol Genet; 1997 Mar; 23(2):123-33. PubMed ID: 9330640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of small clusters of divergent amino acids that mediate the opposing effects of ras and Krev-1.
    Zhang K; Noda M; Vass WC; Papageorge AG; Lowy DR
    Science; 1990 Jul; 249(4965):162-5. PubMed ID: 2115210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of amino acid residues required for Ras p21 target activation.
    Marshall MS; Davis LJ; Keys RD; Mosser SD; Hill WS; Scolnick EM; Gibbs JB
    Mol Cell Biol; 1991 Aug; 11(8):3997-4004. PubMed ID: 1906576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cloning of rat Krev-1 cDNA and analysis of the mRNA levels in normal and NMU-induced mammary carcinomas.
    Hong HJ; Hsu LC; Gould MN
    Carcinogenesis; 1990 Jul; 11(7):1245-7. PubMed ID: 2142634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. smg/rap1/Krev-1 p21s inhibit the signal pathway to the c-fos promoter/enhancer from c-Ki-ras p21 but not from c-raf-1 kinase in NIH3T3 cells.
    Sakoda T; Kaibuchi K; Kishi K; Kishida S; Doi K; Hoshino M; Hattori S; Takai Y
    Oncogene; 1992 Sep; 7(9):1705-11. PubMed ID: 1323817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
    Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
    Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A ras-related gene with transformation suppressor activity.
    Kitayama H; Sugimoto Y; Matsuzaki T; Ikawa Y; Noda M
    Cell; 1989 Jan; 56(1):77-84. PubMed ID: 2642744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.